Consortium Clinical Research Private Limited, a active private limited company, was established on 16 January 2007 in Delhi, Delhi, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U24233DL2007PTC157999. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Nagalakshm Kondaswamy Thirvvenkataswamy (Director), Anandapadmanabhan Perumal Swamy (Managing Director). Past directors included Anandapadmanabhan Perumal Swamy. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 325, Agarwal Plaza Sector 14, Prashant Vihar, Delhi, Delhi, 110085.
U24233DL2007PTC157999
157999
16 January 2007
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Consortium Clinical Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nagalakshm Kondaswamy Thirvvenkataswamy | Director | 16 Jan 2007 | Current |
| Anandapadmanabhan Perumal Swamy | Managing Director | 16 Jan 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Dec 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Consortium Clinical Research Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.14% increase. The company also saw a substantial improvement in profitability, with a 10.75% increase in profit. The company's net worth observed a substantial decline by a decrease of 40.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Consortium Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Consortium Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Consortium Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Consortium Clinical Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Consortium Clinical Research Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Progress on Consortium Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was documented.
The activity Nagalakshm Kondaswamy Thirvvenkataswamy was appointed as a Director was appointed as a Director on 16 Jan 2007 & has been associated with this company since 18 years 10 months . was completed.
Anandapadmanabhan Perumal Swamy was appointed as a Managing Director was appointed as a Managing Director on 16 Jan 2007 & has been associated with this company since 18 years 10 months . was recorded as a recent event.
The activity Consortium Clinical Research Private Limited was registered on 16 Jan 2007 with Roc Delhi & aged 18 years 10 months as per MCA records. was completed.
The CIN of Consortium Clinical Research Private Limited is U24233DL2007PTC157999.
Consortium Clinical Research Private Limited is headquartered at 325, Agarwal Plaza Sector 14, Prashant Vihar, Delhi, Delhi, 110085.
Consortium Clinical Research Private Limited was incorporated on 16 January 2007.
The current directors of Consortium Clinical Research Private Limited are
The primary industry of Consortium Clinical Research Private Limited is Pharma.
Consortium Clinical Research Private Limited is unlisted.
The authorized capital of Consortium Clinical Research Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Consortium Clinical Research Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX